Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

INMD - Inmode Ltd


IEX Last Trade
16.69
0.690   4.134%

Share volume: 1,263,341
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$16.00
0.69
4.31%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
55%
Profitability 75%
Dept financing 5%
Liquidity 75%
Performance 42%
Company vs Stock growth
vs
Performance
5 Days
2.83%
1 Month
-6.60%
3 Months
-11.45%
6 Months
-22.92%
1 Year
-58.30%
2 Year
-47.47%
Key data
Stock price
$16.69
P/E Ratio 
9.41
DAY RANGE
N/A - N/A
EPS 
$1.73
52 WEEK RANGE
$15.41 - $39.48
52 WEEK CHANGE
-$0.58
MARKET CAP 
1.403 B
YIELD 
N/A
SHARES OUTSTANDING 
83.982 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$980,478
AVERAGE 30 VOLUME 
$999,317
Company detail
CEO:
Region: US
Website: inmodemd.com
Employees: 425
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and contraction. lumecca: broad spectrum pulsed light for rejuvenation of photo-damaged skin in a wide variety of skin types. diolaze: ultra fast diode hair removal featuring simultaneous 3pc (pre, parallel, and post cooling) technology and state of the art pulsing and power. bodyfx: non-invasive body contouring for buttocks, abdomen, flanks and thighs with a.c.e. technology

Recent news